Millar Alastair J W, Gupte Girish, Sharif Khalid
University of Cape Town and Red Cross Children's Hospital, Cape Town, South Africa.
Semin Pediatr Surg. 2009 Nov;18(4):258-62. doi: 10.1053/j.sempedsurg.2009.07.007.
Intestinal transplantation (ITx) has now become an accepted form of replacement therapy for intestinal failure (IF) and its complications. Disorders of bowel motility may represent up to 25% of patients on waiting lists for ITx. Some patients with short bowel as a cause for IF may also have dysmotile bowel. Underlying pathology of the intestine is heterogeneous and may be due to abnormalities in the nerve supply, intestinal smooth muscle, or may be regarded as idiopathic (chronic intestinal pseudo-obstruction). Outcome after ITx for dysmotility has previously been guarded, but providing the appropriate graft is used and taking into account the functional motility of residual bowel, it should not be different from other indications. The subject is reviewed emphasizing the potential pitfalls in case selection and management. The results of the ITx unit in Birmingham, UK are briefly reviewed.
肠道移植(ITx)现已成为治疗肠衰竭(IF)及其并发症的一种公认的替代疗法。肠道动力障碍患者在等待ITx的名单中可能占比高达25%。一些因短肠导致IF的患者也可能存在肠道动力障碍。肠道的潜在病理情况多种多样,可能是由于神经供应、肠道平滑肌异常,或者可能被视为特发性(慢性肠道假性梗阻)。此前,针对动力障碍进行ITx后的结果并不乐观,但如果使用合适的移植物并考虑残余肠道的功能动力,其结果应与其他适应症无异。本文对该主题进行综述,重点强调病例选择和管理中可能存在的陷阱。并简要回顾了英国伯明翰ITx单位的结果。